Filing Details

Accession Number:
0001209191-15-061186
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-16 16:37:56
Reporting Period:
2015-07-14
Filing Date:
2015-07-16
Accepted Time:
2015-07-16 16:37:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1624033 Yao Wenqing 1801 Augustine Cut-Off
Wilmington DE 19803
Evp, Discovery Medicinal And P No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-14 7,850 $14.72 29,389 No 4 M Direct
Common Stock Disposition 2015-07-14 7,850 $114.75 21,539 No 4 S Direct
Common Stock Acquisiton 2015-07-15 5,000 $17.79 26,539 No 4 M Direct
Common Stock Disposition 2015-07-15 5,000 $119.75 21,539 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-07-14 7,850 $0.00 7,850 $14.72
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2015-07-15 5,000 $0.00 5,000 $17.79
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-01-24 No 4 M Direct
30,354 2019-01-18 No 4 M Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  2. Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
  3. Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.